Merrimack Pharmaceuticals
MACK
#8010
Rank
NZ$0.39 B
Marketcap
$26.38
Share price
0.00%
Change (1 day)
6.92%
Change (1 year)

Earnings for Merrimack Pharmaceuticals (MACK)

Earnings in 2024 (TTM): -NZ$3.72 Million

According to Merrimack Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -NZ$3.8 Million a decrease over its 2022 earnings that were of -NZ$3.8 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Merrimack Pharmaceuticals from 2010 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$3.72 Million-1.97%
2023 -NZ$3.8 Million0.09%
2022 -NZ$3.8 Million-16.9%
2021 -NZ$4.57 Million-49.89%
2020 -NZ$9.11 Million-75.39%
2019 -NZ$36.99 Million-68.58%
2018 -NZ$0.12 Billion-19.4%
2017 -NZ$0.15 Billion-36.46%
2016 -NZ$0.23 Billion2.54%
2015 -NZ$0.23 Billion96.78%
2014 -NZ$0.12 Billion-45.44%
2013 -NZ$0.21 Billion
2010 -NZ$80.97 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$13.84 B-351,673.26%๐Ÿ‡ซ๐Ÿ‡ท France
-NZ$50.64 Million 1,185.48%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.28 Billion 6,808.72%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.38 Billion 9,523.90%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$65.85 Million 1,571.40%๐Ÿ‡บ๐Ÿ‡ธ USA